Neoadjuvant chemotherapy in the setting of locally advanced olfactory neuroblastoma with intracranial extension
Olfactory neuroblastoma (esthesioneuroblastoma) is a rare malignant tumor of neuroectodermal origin. With only about 1,000 cases reported, there are no clear guidelines regarding management of this disease. Intracranial extension and orbital involvement have been shown to be independent risk factor...
Main Authors: | Raid Aljumaily, John S. Nystrom, Richard O. Wein |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Rare Tumors |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/rt/article/view/2180 |
Similar Items
-
FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs
by: Meizhen Lin, et al.
Published: (2024-09-01) -
The role of chemotherapy in the management of olfactory neuroblastoma: A 40‐year surveillance, epidemiology, and end results registry study
by: Ryan J. Brisson, et al.
Published: (2021-06-01) -
Olfactory Neuroblastoma: Re-Evaluating the Paradigm of Intracranial Extension and Cyst Formation
by: Rebecca A. Dumont, et al.
Published: (2022-03-01) -
Olfactory neuroblastoma: diagnosis, management, and current treatment options
by: Alicia Tosoni, et al.
Published: (2023-10-01) -
Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy
by: Xian-Ying Lu, et al.
Published: (2022-06-01)